LONDON (dpa-AFX) - Asterand plc (ATD.L) Friday reported its continued expectation of year-over-year growth in 2011 revenues, thanks to an improvement in its Tissue Business, whose annual revenues are now seen to be on par with the prior-year. The segment had seen a downturn in the third-quarter.
Referring to its prior announcement regarding its default on debts totaling $9 million, the company noted the extension of its evaluation of such actions as refinancing or sale of business that would help resolve balance sheet 'issues'. Further, the company said that, since June 30, 2011, it had also seen management changes due to the resignation of chief executive officer, or CEO, Martyn Coombs and chief financial officer, or CFO, John Stchur.
While Asterand's chairman Jack Davis currently serves as Interim CEO, the selection of a permanent replacement has been postponed until completion of the formal sales process, the company added. Davis said 'Whilst the expected increase in revenues for the final quarter has improved the general outlook, our balance sheet issues continue to dominate the actions of the Company.'
Copyright RTT News/dpa-AFX
© 2011 AFX News
